Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
Add more filters











Publication year range
1.
Anticancer Res ; 41(12): 6077-6086, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34848462

ABSTRACT

AIM: We identified chemical components that exhibited antitumor activity against oral squamous cell carcinoma (OSCC) cells and examined their effective concentrations and additive and/or synergistic effects in combinational usage on the proliferation, apoptosis and cell cycle of OSCC cells. MATERIALS AND METHODS: Using high-performance liquid chromatography, nuclear magnetic resonance spectroscopy and electrospray ionization-mass spectrometry, we identified the main chemical components of the methanol extracts from Paeonia lutea. We investigated the pharmaceutical effects of those components on the proliferation, apoptosis, and cell cycle of an OSCC cell line, SAS, using the tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) and caspase assays, as well as flow cytometry cell cycle analysis. We also examined the effects of those components on the mitogen-activated protein kinase signal transduction pathway by western blotting. Finally, the effects on normal human epidermal keratinocyte cells were also examined in similar experiments. RESULTS: Three chemicals have been identified in P. lutea leaves using high performance liquid chromatography: gallic acid methyl ester (GAME), pentagalloyl glucose (PGG) and paeoniflorin (PF). Both GAME and PGG significantly suppressed cell proliferation, and their combined effects were synergistic, while the effect of PF was minimal. However, those chemicals did not induce apoptosis. Cell cycle and western blotting analysis showed that the suppressive effects on cell proliferation resulted from G2 arrest and the suppression of phosphorylation of Akt/PKB. No effect was identified on normal human epidermal keratinocyte cells. CONCLUSION: These results indicate that GAME and PGG are the main chemical components of P. lutea leaves that have potential anti-cancer therapeutic effects.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Mouth Neoplasms/drug therapy , Paeonia/chemistry , Plant Extracts/chemistry , Plant Leaves/chemistry , Humans
2.
Biochim Biophys Acta Mol Cell Biol Lipids ; 1863(7): 772-782, 2018 07.
Article in English | MEDLINE | ID: mdl-29654827

ABSTRACT

Brown adipose tissue is specialized to generate heat by dissipating chemical energy and may provide novel strategies for obesity treatment in humans. Recently, advances in understanding the pharmacological and dietary agents that contribute to the browning of white adipose tissue have been made to alleviate obesity by promoting energy expenditure. Krill oil is widely used as a health supplement in humans. In this study, the components from krill oil that promote adipogenesis of 3T3-L1 cells were screened to reveal palmitoyl lactic acid (PLA) as a promoter of adipogenesis. The PLA-induced adipocytes contained large number of small lipid droplets. Moreover, similar to the peroxisome proliferator-activated receptor (PPAR)γ agonists, pioglitazone and rosiglitazone, PLA significantly enhances adipogenesis in the presence of dexamethasone compared with PLA alone. Treatment with PLA causes a brown fat-like phenotype in 3T3-L1 cells by enhanced expression of various brown/beige cell-specific genes, such as PR domain containing 16 (Prdm16) and peroxisome proliferative activated receptor, gamma, coactivator 1 alpha (Pgc1a), as well as adiponectin gene. The expression profile of the brown/beige cell-specific genes induced by PLA was similar to that of the PPARγ agonist in 3T3-L1 cells. Our findings suggest that PLA induces a brown fat-like phenotype and, thus, likely has therapeutic potential in treating obesity.


Subject(s)
Adipocytes/drug effects , Adipogenesis/drug effects , Adipose Tissue, Brown/drug effects , Lactic Acid/analogs & derivatives , Lactic Acid/pharmacology , Palmitates/pharmacology , 3T3-L1 Cells , Adipocytes/metabolism , Adipose Tissue, Brown/metabolism , Animals , Cell Differentiation/drug effects , Lactic Acid/chemistry , Lactic Acid/therapeutic use , Lipid Droplets/drug effects , Lipid Droplets/metabolism , Mice , Obesity/drug therapy , Obesity/metabolism , PPAR gamma/agonists , PPAR gamma/metabolism , Palmitates/chemistry , Palmitates/therapeutic use , Phenotype , Pioglitazone/pharmacology , Rosiglitazone/pharmacology
3.
Mar Biotechnol (NY) ; 19(2): 157-163, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28378103

ABSTRACT

A new technology employing Raman spectroscopy is attracting attention as a powerful biochemical technique for the detection of beneficial and functional food nutrients, such as carotenoids and unsaturated fatty acids. This technique allows for the dynamic characterization of food nutrient substances for the rapid determination of food quality. In this study, we attempt to detect and measure astaxanthin from salmon fillets using this technology. The Raman spectra showed specific bands corresponding to the astaxanthin present in salmon and the value of astaxanthin (Raman band, 1518 cm-1) relative to those of protein/lipid (Raman band, 1446 cm-1) in the spectra increased in a dose-dependent manner. A standard curve was constructed by the standard addition method using astaxanthin as the reference standard for its quantification by Raman spectroscopy. The calculation formula was established using the Raman bands typically observed for astaxanthin (i.e., 1518 cm-1). In addition, we examined salmon fillets of different species (Atlantic salmon, coho salmon, and sockeye salmon) and five fillets obtained from the locations (from the head to tail) of an entire Atlantic salmon. Moreover, the sockeye salmon fillet exhibited the highest astaxanthin concentration (14.2 mg/kg), while coho salmon exhibited an intermediate concentration of 7.0 mg/kg. The Raman-based astaxanthin concentration in the five locations of Atlantic salmon was more strongly detected from the fillet closer to the tail. From the results, a rapid, convenient Raman spectroscopic method was developed for the detection of astaxanthin in salmon fillets.


Subject(s)
Pigments, Biological/analysis , Salmon/metabolism , Seafood/analysis , Animals , Food Quality , Muscle, Skeletal/chemistry , Spectrum Analysis, Raman , Tissue Distribution , Xanthophylls/analysis
4.
Article in English | MEDLINE | ID: mdl-27293462

ABSTRACT

Squamous cell carcinoma (SCC) is one of the most common cancers of the head and neck region worldwide and is generally treated surgically in combination with radiotherapy and/or chemotherapy. However, anticancer agents have numerous serious side effects, and alternative, less toxic agents that are effective as chemotherapeutics for SCC are required. The Paeoniaceae family is widely used in traditional Chinese medicine. We examined methanol and butanol extracts of Paeonia lutea (P. lutea) leaves for their potential as an anticancer agent. Both extracts decreased the proliferation of SCC cells, induced apoptotic cell death, and modulated migration, adhesion, chemotaxis, and haptotaxis in an extracellular matrix- (ECM-) dependent manner due to altered expression of several integrin subunits. Subsequently, SCC cells were subcutaneously transplanted into athymic nude mice; the extracts reduced the metastasis of SCC cells but had little effect on the volume of the primary tumor or survival or body weight of the mice. The results suggest that the extracts may hold promise for preventing cancer metastasis.

5.
Exp Ther Med ; 10(2): 641-646, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26622368

ABSTRACT

Shark liver oil (SLO) has long been used as a traditional health food, with a particular benefit for vascular health, in Japan. The aim of this study was to assess the effect of dietary supplementation with SLO on arterial stiffness and peripheral microvascular function in otherwise healthy middle-aged and older males with slightly increased arterial stiffness. A randomized, double-blind, placebo-controlled, parallel study design was used to assign 41 healthy males with a mean age of 59.0±4.0 years (range, 45-69 years) to either SLO (n=21) or placebo (n=20) treatment for eight weeks. The effects on arterial stiffness and peripheral microvascular function were assessed by the cardio-ankle vascular index (CAVI) and by measurement of hand blood flow to cutaneous tissues using a laser Doppler perfusion imaging (LDPI) technique, respectively. Although the magnitude of the changes in the CAVI value during the eight-week intervention for the SLO group did not significantly differ from that for the placebo group, the changes in the CAVI value for the former group were significantly associated (r=0.575, P<0.01) with age. It was also found that the LDPI values at week 8 were significantly lowered (P<0.05) compared with the baseline values in the placebo group, while no change was observed in the SLO group, resulting in a significant difference in the changes between the two groups (P=0.002). Neither SLO supplementation-related adverse side-effects nor any abnormal changes in routine laboratory tests, including lipid profiles and anthropometric and haemodynamic parameters, were observed throughout the intervention. SLO may have the potential to safely improve vascular health in middle-aged and elderly males.

6.
BMC Complement Altern Med ; 14: 29, 2014 Jan 17.
Article in English | MEDLINE | ID: mdl-24438322

ABSTRACT

BACKGROUND: Osteoporosis (OP) is one of the most serious diseases in the modern world, and OP patients frequently suffer from fragility fractures in the hip, spine and wrist, resulting in a limited quality of life. Although bisphosphonates (BPs) are the most effective class of anti-bone-resorptive drugs currently available and the most commonly prescribed for the clinical treatment of OP, they are known to cause serious side effects such as bisphosphonate-related osteonecrosis of the jaw. Novel therapeutic materials that can replace the use of BPs have therefore been developed. METHODS: We commenced an institutional collaborative project in which candidates of herbal extracts were selected from more than 400 bioactive herbal products for their potential therapeutic effects not only in OP, but also in oral and skeletal diseases. In the present study, we report on 3 Chinese medical herbal extracts from the root barks of Melia azedarach, Corydalis turtschaninovii, and Cynanchum atratum. RESULTS: All of these extracts inhibited osteoclast proliferation and induced apoptosis by up-regulation of caspase activity and increase of mitochondrial pro-apoptotic proteins expression. Furthermore, the extracts enhanced differentiation, but did not affect proliferation of both osteoblasts and chondrocytes. The osteo-inducible effect was also observed in cultured primary bone marrow cells. CONCLUSIONS: Although these extracts have been utilized in traditional Chinese medicine for hundreds of years, there are no reports to our knowledge, on their therapeutic effects in OP. In this study, we elucidate the potency of these herbal extracts as novel candidates for OP therapy.


Subject(s)
Bone and Bones/drug effects , Chondrocytes/drug effects , Drugs, Chinese Herbal/pharmacology , Magnoliopsida , Osteoblasts/drug effects , Osteoclasts/drug effects , Osteoporosis , Apoptosis/drug effects , Bone Marrow Cells/drug effects , Bone and Bones/cytology , Caspases/metabolism , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Corydalis , Cynanchum , Diphosphonates/adverse effects , Diphosphonates/therapeutic use , Drugs, Chinese Herbal/therapeutic use , Humans , In Vitro Techniques , Melia , Osteoporosis/prevention & control , Phytotherapy , Plant Bark , Plant Roots , Quality of Life , Up-Regulation/drug effects
7.
Oncol Rep ; 30(6): 2665-71, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24064583

ABSTRACT

Cis-platinum (II) diammine dichloride (CDDP) is a platinum-based anticancer agent, and is often used for chemotherapy for malignant tumors, albeit CDDP has serious side-effects, including xerostomia (dry mouth). Since patients with xerostomia have reduced quality of life, it is urgent and important to identify nontoxic and natural agents capable of reducing the adverse effect of chemotherapy on salivary gland function. Therefore, we commenced an institutional collaborative project in which candidates of herbal extracts were selected from more than 400 bioactive herbal products for their potential therapeutic effects not only on xerostomia, but also on oral diseases. In the present study, we report on two Chinese medical herbal extracts from the root barks of Juncus effusus and Paeonia suffruticosa. The two extracts showed a protective effect in NS-SV-Ac cells from the cytotoxicity and apoptosis caused by CDDP. The effect was dependent on the p53 pathway, protein kinase B/Akt 1 and mitochondrial apoptosis-related proteins (i.e. Bcl-2 and Bax), but was not dependent on nuclear factor κB. Notably, the apoptosis-protective effect of the extracts was not observed in adenocystic carcinoma cell lines. Although these extracts have been utilized in traditional Chinese medicine for hundreds of years, there are no reports to our knowledge, on their therapeutic effects on xerostomia. Thus, in the present study, we elucidated the potency of these herbal extracts as novel candidates for xerostomia to improve the quality of life of patients undergoing chemotherapy.


Subject(s)
Apoptosis/drug effects , Drugs, Chinese Herbal/pharmacology , Neoplasms/drug therapy , Paeonia/chemistry , Xerostomia/drug therapy , Acinar Cells/drug effects , Cisplatin/administration & dosage , Drugs, Chinese Herbal/chemistry , Gene Expression Regulation, Neoplastic , Humans , Neoplasms/pathology , Plant Bark/chemistry , Plant Roots/chemistry , Salivary Glands/drug effects , Signal Transduction/drug effects , Xerostomia/chemically induced , Xerostomia/pathology , bcl-2-Associated X Protein/metabolism
8.
Mol Clin Oncol ; 1(1): 105-111, 2013 Jan.
Article in English | MEDLINE | ID: mdl-24649131

ABSTRACT

Various herb products derived from plants have potent biological effects including anticancer activity. In the present study, the antitumor activity of a herbal product derived from the Scutellaria baicalensis (S. baicalensis) was examined, using in vitro assays in a human oral squamous cell carcinoma (OSCC) cell line. Results showed that S. baicalensis root extract at the concentration of 100 µg/ml inhibited monolayer- and anchorage-independent growth in human OSCC cell lines, while not affecting the adhering abilities of cells. This suggested that it did not alter the expression of any of the adhesion receptors that mediate cell-extracellular matrix (ECM) interactions. The S. baicalensis root extract demonstrated potent cytostatic and apoptotic effects due to the downregulation of the cyclin-dependent kinase 4 expression and its partner cyclin D1, resulting in G1 arrest and poly (ADP-ribose) polymerase (PARP) cleavage. Additionally, the S. baicalensis root extract was found to have blocked vascular endothelial growth factor (VEGF)-induced migration and tube formation in human endothelial cells. Taken together, these results demonstrate that as a herbal product, the S. baicalensis root extract is a potential inhibitor of tumori- and angiogenesis and may be valuable in the development of pharmaceutical medications for the treatment of oral squamous cell carcinoma.

9.
J Nutr Sci Vitaminol (Tokyo) ; 58(1): 63-7, 2012.
Article in English | MEDLINE | ID: mdl-23007070

ABSTRACT

While the industrial value of fruits has long been recognized, only recently have the leaves of fruit trees been considered to have immense and mostly-untapped potential. In the present study, the physiological effects of apple leaf extract in mice were investigated. In addition, we sought to elucidate the active principle(s) and examined its potential for application. Apple leaf extract suppressed postprandial elevation of the blood glucose level and increased the residual amount of glucose in the small intestine in glucose-loaded mice compared with those in control mice. Bioassay-guided fractionation led to an active component that was identified as phloridzin, a known SGLT inhibitor, based on an analysis of its spectral data. With regard to an anti-hyperglycemic effect, extraction with ethanol from leaves of apple tree gave the best results. These effects decreased with heating during the extraction procedure. Since bolus ingestion of the extract did not affect blood glucose levels in normal mice with or without an overnight fast, the inhibitory effects on glucose absorption were not considered to be associated with unspecific gastrointestinal impairment and the extract did not cause hypoglycemia at a normally effective dose. Therefore, the leaf parts of apple tree may be a promising candidate as an industrial resource for maintaining good health in the future.


Subject(s)
Blood Glucose/metabolism , Hypoglycemic Agents/isolation & purification , Hypoglycemic Agents/pharmacology , Malus/chemistry , Phytotherapy/methods , Plant Extracts/pharmacology , Postprandial Period/drug effects , Animals , Hypoglycemic Agents/chemistry , Male , Mice , Nuclear Magnetic Resonance, Biomolecular , Phlorhizin/chemistry , Phlorhizin/isolation & purification , Phlorhizin/pharmacology , Plant Extracts/chemistry , Plant Leaves/chemistry
10.
Biol Pharm Bull ; 35(8): 1264-8, 2012.
Article in English | MEDLINE | ID: mdl-22863923

ABSTRACT

Peach leaf extract has anti-hyperglycemic effects on the postprandial blood glucose level in glucose-loaded mice. In our previous study, the mechanism of action was considered to be the inhibition of glucose absorption in the small intestine. To elucidate the active principle in peach leaf, purification of the active compound and a structure determination were performed. With the use of bioassay-guided fractionation using glucose-loaded mice, the acetylated kaempferol glycoside multiflorin A (MFA), a potent inhibitor of glucose absorption from the intestine, was isolated from the MeOH extract of leaf of the edible peach Prunus persica. The structure was identified by HPLC using thiazolizine derivatives and by an analysis of its spectral data. The inhibitory effect of MFA against glucose absorption was demonstrated in the dose dependent manner in mice. However, as the deacetylated analog of MFA, multiflorin B did not show the activity at the in vivo, the activity of MFA was suggested to depend on the acetyl group on the sugar moiety. This is the first report of anti-hyperglycemic activity of MFA in peach leaf extract. MFA may be useful in functional foods or medicines for preventing the postprandial absorption of glucose in hyperglycemia.


Subject(s)
Chromones/pharmacology , Glucose/metabolism , Glycosides/pharmacology , Hypoglycemic Agents/pharmacology , Intestine, Small/drug effects , Plant Extracts/pharmacology , Prunus/chemistry , Animals , Chromones/chemistry , Chromones/isolation & purification , Dose-Response Relationship, Drug , Glycosides/chemistry , Glycosides/isolation & purification , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/isolation & purification , Intestinal Absorption/drug effects , Intestine, Small/metabolism , Male , Mice , Mice, Inbred Strains , Molecular Structure , Phytotherapy , Plant Extracts/chemistry , Plant Leaves/chemistry
11.
J Nutr Sci Vitaminol (Tokyo) ; 58(2): 129-35, 2012.
Article in English | MEDLINE | ID: mdl-22790571

ABSTRACT

Oral administration of Terminalia catappa extract (TCE; 1,000 mg/kg) for 5 wk suppressed bone weight loss and trabecular bone loss in ovariectomized mice. An in vitro experiment showed that TCE (1.3-20 µg/mL) did not increase alkaline phosphatase activity, which would indicate osteoclast formation, in osteoblast-like 3T3-L1 cells. On the other hand, TCE (12.5 µg/mL) markedly decreased the number of tartrate resistant acid phosphatase (TRAP)-positive multinucleated cells, which would indicate osteoclast formation, in a co-culture system (bone marrow cells/osteoblastic UAMS-32 cells). A detailed analysis of the stages of osteoclast differentiation revealed that TCE mainly suppressed the differentiation of bone marrow mononuclear cells into osteoclast progenitor cells in the presence of M-CSF and TGF-ß. An additional experiment using fractionated TCE revealed that the water-soluble fraction suppressed the bone weight loss in OVX-mice and osteoclast differentiation in vitro. Therefore, the suppressive effects of TCE on bone weight loss in mice might be due to the suppressive effects of highly polar components on the early stage of osteoclast differentiation.


Subject(s)
Cell Differentiation/drug effects , Osteoclasts/cytology , Osteoporosis/prevention & control , Plant Extracts/administration & dosage , Plant Leaves/chemistry , Terminalia/chemistry , 3T3-L1 Cells , Animals , Bone and Bones/pathology , Female , Mice , Organ Size/drug effects , Osteoclasts/drug effects , Ovariectomy
12.
Anticancer Res ; 32(7): 2625-30, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22753719

ABSTRACT

Currently there is growing use of complementary and alternative anticancer medicines worldwide, and considerable interest in finding anticancer drugs among Chinese medicinal herbs. The aim of this study was to determine the antitumor activity of the root bark of Paeonia moutan (RBPM) in human squamous cell carcinoma (OSCC) cells. Cell lines derived from human oral squamous cell carcinoma (HSC2, 3, 4, SAS) were tested with different concentrations of RBPM (1-100 µg/ml) using a series of in vitro assay systems. RBPM at a concentration of 100 µg/ml inhibited monolayer and anchorage-independent growth, and interrupted coordinated migration. RBPM activated the phosphorylation of extracellular signal-regulated kinase (ERK) and serine/threonine kinase AKT in 30 min; then, at a later stage (after 6 hours) exhibited potent cytostatic, pro-apoptotic effects through the down-regulation of the expression of cyclin-dependent kinase 4 and its partner cyclin D1, and poly(ADP-ribose) polymerase cleavage. We found direct evidence that RBPM induces apoptotic cell death via DNA fragmentation. Taken together, the antitumor activity of RBPM was demonstrated through antiproliferative and apoptotic effects.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Mouth Neoplasms/drug therapy , Paeonia/chemistry , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , Apoptosis/drug effects , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/pathology , Cell Adhesion/drug effects , Cell Growth Processes/drug effects , Cell Line, Tumor , Cell Movement/drug effects , Humans , MAP Kinase Signaling System/drug effects , Mouth Neoplasms/enzymology , Mouth Neoplasms/pathology , Phytotherapy
13.
Phytother Res ; 26(4): 475-81, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22508359

ABSTRACT

The antiobesity effects of Chinese black tea (Pu-erh tea) and of gallic acid (GA) were investigated using in vitro and in vivo assays. Chinese black tea extract (BTE) and GA inhibited pancreatic lipase activity in a dose-dependent manner in vitro; the IC(inhibitory concentration)(50) values were 101.6 and 9.2 µg/mL, respectively. Black tea extract (50, 100 mg/kg body weight (b.w.)) and GA (15, 45 mg/kg b.w.) significantly suppressed the elevation of blood triglyceride after oral administration of a corn oil emulsion (8 mL oil/kg b.w.) to male ddY mice. Moreover, the antiobesity effects of BTE and GA were also evaluated in a mouse model of diet-induced obesity. Female ddY mice were divided into seven groups; normal diet (ND) group, high fat diet (HFD) group, BTE (0.2% and 0.6% of diets) groups, and GA (0.007%, 0.02% and 0.1% of diets) groups; the experimental groups were fed the test diets for 12 weeks. The BTE 0.6% and GA 0.1% groups showed significant suppression of weight gain. The weight of parametrial adipose tissue was strongly correlated with the body weight. These results suggest that GA contributes to the antiobesity effect of BTE as an active constituent by inhibiting pancreatic lipase activity.


Subject(s)
Anti-Obesity Agents/pharmacology , Drugs, Chinese Herbal/pharmacology , Gallic Acid/pharmacology , Obesity/prevention & control , Tea/chemistry , Adipose Tissue/drug effects , Animals , Anti-Obesity Agents/administration & dosage , Body Weight , Caffeine/administration & dosage , Caffeine/pharmacology , Corn Oil/administration & dosage , Diet, High-Fat/adverse effects , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Drugs, Chinese Herbal/administration & dosage , Enzyme Activation , Feces/chemistry , Female , Gallic Acid/administration & dosage , Inhibitory Concentration 50 , Lipase/metabolism , Male , Mice , Mice, Obese , Obesity/drug therapy , Pancreas/enzymology
14.
Biosci Biotechnol Biochem ; 76(1): 89-94, 2012.
Article in English | MEDLINE | ID: mdl-22232239

ABSTRACT

The crude extract of peach leaves dose-dependently suppressed the postprandial elevation in the blood glucose level after an oral administration of soluble starch to mice. This study examines the mechanism for this suppressive effect in vivo. An oral carbohydrate-loading test on mice showed that the peach leaf extract suppressed the glucose-induced increase in the blood level of glucose, but without affecting the insulin level. An enteral soluble starch and glucose loading test on mice also showed that the crude extract (1,000 mg/kg) significantly suppressed the postprandial elevation of the blood glucose level and increased the amount of glucose that remained in the intestine to within the same range as that with phloridzin (500 mg/kg), a natural sodium-dependent glucose transporter (SGLT)-specific inhibitor. In contrast, the extract did not suppress the postprandial elevation of the blood triglyceride and cholesterol levels in mice, and did not affect the normal blood glucose level in a feeding test for 21 d. These results reveal that the extract of peach leaves suppressed the postprandial elevation of blood glucose level by inhibiting the absorption of glucose in the small intestine of mice.


Subject(s)
Glucose/metabolism , Intestinal Absorption/drug effects , Intestine, Small/drug effects , Intestine, Small/metabolism , Plant Extracts/pharmacology , Plant Leaves/chemistry , Prunus/chemistry , Animals , Cholesterol/metabolism , Enteral Nutrition , Hypoglycemic Agents/pharmacology , Insulin/blood , Male , Mice , Postprandial Period/drug effects , Solubility , Starch/chemistry , Starch/metabolism , Triglycerides/metabolism
15.
Biosci Biotechnol Biochem ; 76(1): 189-92, 2012.
Article in English | MEDLINE | ID: mdl-22232261

ABSTRACT

The methanol extract of Dypsis lutescens leaves showed inhibitory effects on lipase activity in vitro and on triglyceride accumulation in 3T3-L1 pre-adipocytes. Further experiments using the extract on mice demonstrated a suppressive effect on the postprandial elevation of blood triglyceride level and an anti-obesity effect on obese mice induced by a high-fat diet. D. lutescens will accordingly be useful for preventing obesity.


Subject(s)
Arecaceae/chemistry , Plant Extracts/pharmacology , Plant Leaves/chemistry , Triglycerides/metabolism , 3T3-L1 Cells , Absorption/drug effects , Adipocytes/cytology , Adipocytes/drug effects , Adipocytes/metabolism , Animals , Cell Differentiation/drug effects , Male , Mice
17.
Chem Pharm Bull (Tokyo) ; 59(5): 672-5, 2011.
Article in English | MEDLINE | ID: mdl-21532209

ABSTRACT

A new compound, pycnalin (1), together with four known compounds, ginnalins A (2), B (3), C (4), and 3,6-di-O-galloyl-1,5-anhydro-D-glucitol (3,6-di-GAG) (5), were isolated from Acer pycnanthum. The structure of 1 was determined on the basis of 2D-NMR spectral data and synthesis of 1. Pycnalin (1) is the first 1,5-anhydro-D-mannitol linked to a gallic acid, while compounds 2-5 were 1,5-anhydro-D-glucitol linked to gallic acids. All compounds were tested in vitro for α-glucosidase inhibitory and 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities. Pycnalin (1) exhibited moderate α-glucosidase inhibitory activity as well as free radical scavenging activity. Ginnalin A (2) and 3,6-di-GAG (5), which have two galloyl groups, exhibited potent α-glucosidase inhibition, compared to those of other compounds 1, 3, and 4 containing a galloyl group. These results suggest that α-glucosidase inhibition is influenced by the number of galloyl groups.


Subject(s)
Acer/chemistry , Enzyme Inhibitors/pharmacology , Glycoside Hydrolase Inhibitors , Glycosides/pharmacology , Hypoglycemic Agents/pharmacology , Acer/metabolism , Biphenyl Compounds/chemistry , Biphenyl Compounds/pharmacology , Deoxyglucose/analogs & derivatives , Deoxyglucose/chemistry , Deoxyglucose/isolation & purification , Deoxyglucose/pharmacology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/isolation & purification , Free Radical Scavengers/chemistry , Free Radical Scavengers/pharmacology , Gallic Acid/analogs & derivatives , Gallic Acid/chemistry , Gallic Acid/isolation & purification , Gallic Acid/pharmacology , Glycosides/chemistry , Glycosides/isolation & purification , Humans , Hypoglycemia/drug therapy , Hypoglycemia/metabolism , Hypoglycemia/pathology , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/isolation & purification , Magnetic Resonance Spectroscopy , Picrates/chemistry , Picrates/pharmacology , Plant Extracts/chemistry , Plant Extracts/metabolism , Sorbitol/analogs & derivatives , Sorbitol/chemistry , Sorbitol/isolation & purification , Sorbitol/pharmacology
18.
J Nutr Sci Vitaminol (Tokyo) ; 57(1): 104-7, 2011.
Article in English | MEDLINE | ID: mdl-21512298

ABSTRACT

The methanolic extract of seeds of the tropical fruit camu-camu was screened for its anti-inflammatory activity in carrageenan-induced paw edema model mice. The extract significantly suppressed both the formation of edema in mice by oral administration and the release of nitric oxide from macrophage-derived RAW 264.7 cells in vitro. Based on the results of a spectroscopic analysis, the active compound was identified by in vivo bioassay-guided fractionation to be 3ß-hydroxy-lup-20(29)-en-28-oic acid, betulinic acid, known as an anti-inflammatory triterpenoid. These findings suggest that camu-camu seed extract is a potentially useful material as a source of betulinic acid and as a functional food for prevention of immune-related diseases.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Edema/drug therapy , Myrtaceae/chemistry , Phytotherapy , Seeds/chemistry , Triterpenes/pharmacology , Analysis of Variance , Animals , Carrageenan/metabolism , Cell Line , Edema/chemically induced , Edema/prevention & control , Functional Food , Macrophages/metabolism , Male , Mice , Nitric Oxide/metabolism , Pentacyclic Triterpenes , Plant Extracts/pharmacology , Betulinic Acid
19.
J Enzyme Inhib Med Chem ; 26(2): 176-80, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20560858

ABSTRACT

The anti-hyperglycaemic effects of the leaves of Acer pycnanthum K. Koch, and the purification and identification of the active compounds were investigated. Extracts of the leaves showed a potent inhibitory effect on the α-glucosidase in both in vivo and in vitro experiments. The fractionation of the crude extract gave two active compounds, ginnalin B (6-O-galloyl-1,5-anhydro-D-glucitol) and ginnalin C (2-O-galloyl-1,5-anhydro-D-glucitol), by spectroscopic analysis. This is the first report that A. pycnanthum and its constituents may be useful for the prevention or treatment of diabetes mellitus.


Subject(s)
Acer/chemistry , Enzyme Activation/drug effects , Hypoglycemic Agents/pharmacology , Plant Extracts/pharmacology , Plant Leaves/chemistry , Sorbitol/analogs & derivatives , Sucrase/antagonists & inhibitors , Animals , Enzyme Inhibitors/pharmacology , Kinetics , Male , Mice , Plant Extracts/chemistry , Sorbitol/chemistry , Sorbitol/pharmacology
20.
Biosci Biotechnol Biochem ; 74(6): 1286-9, 2010.
Article in English | MEDLINE | ID: mdl-20530888

ABSTRACT

We examined the bioactivity of Yamato-mana (Brassica rapa L. Oleifera Group) constituent glucosinolates and found that 3-butenyl glucosinolate (gluconapin) decreased the plasma triglyceride gain induced by corn oil administration to mice. However, phenethyl glucosinolate (gluconasturtiin) had little effect. 2-Propenyl glucosinolate (sinigrin) also reduced the plasma triglyceride level, which suggests that alkenyl glucosinolates might be promising agents to prevent postprandial hypertriglyceridemia.


Subject(s)
Brassica rapa/chemistry , Glucosinolates/pharmacology , Hyperglycemia/drug therapy , Plant Extracts/pharmacology , Absorption/drug effects , Animals , Glucosinolates/therapeutic use , Hyperglycemia/metabolism , Mice , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Triglycerides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL